Grey matter atrophy of basal forebrain and hippocampus in mild cognitive impairment

Journal of Neurology, Neurosurgery and Psychiatry

Volumn 82, Issue 5, 2011, Pages 487-493

  Zhang, Haobo ^a   Trollor, Julian N ^a   Wen, Wei ^a,b   Zhu, Wanlin ^a   Crawford, John D ^a   Kochan, Nicole A ^a,b   Slavin, Melissa J ^a   Brodaty, Henry ^b,c   Reppermund, Simone ^a   Kang, Kristan ^a   Mather, Karen A ^a   Sachdev, Perminder S ^a,b  

^a UNIVERSITY OF NEW SOUTH WALES   (Australia)

^b PRINCE OF WALES HOSPITAL   (Australia)

^c UNIVERSITY OF NEW SOUTH WALES   (Australia)

Author keywords

[No Author keywords available]

Indexed keywords

APOLIPOPROTEIN E4;

AGED; ALLELE; ARTICLE; BRAIN ATROPHY; BRAIN FUNCTION; BRAIN REGION; BRAIN SIZE; CORRELATIONAL STUDY; FEMALE; FOREBRAIN; GRAY MATTER; HEMISPHERIC DOMINANCE; HETEROZYGOSITY; HIPPOCAMPUS; HUMAN; IMAGE ANALYSIS; MAJOR CLINICAL STUDY; MALE; MILD COGNITIVE IMPAIRMENT; MORPHOMETRICS; NEUROIMAGING; NUCLEAR MAGNETIC RESONANCE IMAGING; PRIORITY JOURNAL; PROTEIN EXPRESSION;

EID: 79953881897     PISSN: 00223050     EISSN: 1468330X     Source Type: Journal    
DOI: 10.1136/jnnp.2010.217133     Document Type: Article

References (41)

1. Petersen RC, Roberts RO, Knopman DS, et al. Mild cognitive impairment: ten years later. Arch Neurol 2009; 66: 1447-55.
2. Petersen RC, Doody R, Kurz A, et al. Current concepts in mild cognitive impairment. Arch Neurol 2001; 58: 1985-92. (Pubitemid 33143977)
3. Ries ML, Carlsson CM, Rowley HA, et al. Magnetic resonance imaging characterization of brain structure and function in mild cognitive impairment: a review. J Am Geriatr Soc 2008; 56: 920-34. (Pubitemid 351652416)
4. Stoub TR, deToledo-Morrell L, Stebbins GT, et al. Hippocampal disconnection contributes to memory dysfunction in individuals at risk for Alzheimer's disease. Proc Natl Acad Sci U S A 2006; 103: 10041-5. (Pubitemid 43993619)
5. Becker JT, Davis SW, Hayashi KM, et al. Three-dimensional patterns of hippocampal atrophy in mild cognitive impairment. Arch Neurol 2006; 63: 97-101. (Pubitemid 43063867)
6. Jack CR Jr, Petersen RC, Xu YC, et al. Prediction of AD with MRI-based hippocampal volume in mild cognitive impairment. Neurology 1999; 52: 1397-403. (Pubitemid 29190530)
7. Pennanen C, Kivipelto M, Tuomainen S, et al. Hippocampus and entorhinal cortex in mild cognitive impairment and early AD. Neurobiol Aging 2004; 25: 303-10. (Pubitemid 38220965)
8. Kovacevic S, Rafii MS, Brewer JB. High-throughput, fully automated volumetry for prediction of MMSE and CDR decline in mild cognitive impairment. Alzheimer Dis Assoc Disord 2009; 23: 139-45.
9. Driscoll I, Davatzikos C, An Y, et al. Longitudinal pattern of regional brain volume change differentiates normal aging from MCI. Neurology 2009; 72: 1906-13.
10. Smith CD, Chebrolu H, Wekstein DR, et al. Brain structural alterations before mild cognitive impairment. Neurology 2007; 68: 1268-73. (Pubitemid 46625972)
11. Mesulam MM, Geula C. Nucleus basalis (Ch4) and cortical cholinergic innervation in the human brain: observations based on the distribution of acetylcholinesterase and choline acetyltransferase. J Comp Neurol 1988; 275: 216-40.
12. Zaborszky L, Hoemke L, Mohlberg H, et al. Stereotaxic probabilistic maps of the magnocellular cell groups in human basal forebrain. Neuroimage 2008; 42: 1127-41.
13. Perry EK. The cholinergic system in old age and Alzheimer's disease. Age Ageing 1980; 9: 1-8. (Pubitemid 10215539)
14. Teipel SJ, Flatz WH, Heinsen H, et al. Measurement of basal forebrain atrophy in Alzheimer's disease using MRI. Brain 2005; 128: 2626-44. (Pubitemid 41552947)
15. Hanyu H, Asano T, Sakurai H, et al. MR analysis of the substantia innominata in normal aging, Alzheimer disease, and other types of dementia. AJNR Am J Neuroradiol 2002; 23: 27-32. (Pubitemid 34098257)
16. Muth K, Schonmeyer R, Matura S, et al. Mild cognitive impairment in the elderly is associated with volume loss of the cholinergic basal forebrain region. Biol Psychiatry 2010; 67: 588-91.
17. Grothe M, Zaborszky L, Atienza M, et al. Reduction of basal forebrain cholinergic system parallels cognitive impairment in patients at high risk of developing Alzheimer's disease. Cereb Cortex Published Online First 4 Nov 2009. doi: 10.1093/cercor/bhp232.
18. Hall AM, Moore RY, Lopez OL, et al. Basal forebrain atrophy is a presymptomatic marker for Alzheimer's disease. Alzheimers Dement 2008; 4: 271-9. (Pubitemid 351866120)
19. Whitwell JL, Petersen RC, Negash S, et al. Patterns of atrophy differ among specific subtypes of mild cognitive impairment. Arch Neurol 2007; 64: 1130-8. (Pubitemid 47258072)
20. Farlow MR, He Y, Tekin S, et al. Impact of APOE in mild cognitive impairment. Neurology 2004; 63: 1898-901. (Pubitemid 39532387)
21. Winblad B, Palmer K, Kivipelto M, et al. Mild cognitive impairmentdbeyond controversies, towards a consensus: report of the International Working Group on Mild Cognitive Impairment. J Intern Med 2004; 256: 240-6. (Pubitemid 39222993)
22. Kochan NA, Slavin MJ, Brodaty H, et al. Effect of different impairment criteria on prevalence of 'objective' mild cognitive impairment in a community sample. Am J Geriatr Psychiatry 2010; 18: 711-22.
23. Sachdev P, Brodaty H, Reppermund S, et al. The Sydney Memory and Ageing Study (MAS): Methodology and baseline medical and neuropsychiatric characteristics of an elderly epidemiological non-demented cohort of Australians aged 70-90 years. Int Psychogeriatr 2010; 22: 1248-64.
24. Ashburner J. A fast diffeomorphic image registration algorithm. Neuroimage 2007; 38: 95-113. (Pubitemid 47440133)
25. Fischl B, Salat DH, van der Kouwe AJ, et al. Sequence-independent segmentation of magnetic resonance images. Neuroimage 2004; 23(Suppl 1): S69-84. (Pubitemid 39429376)
26. Hixson JE, Vernier DT. Restriction isotyping of human apolipoprotein E by gene amplification and cleavage with HhaI. J Lipid Res 1990; 31: 545-8. (Pubitemid 20107994)
27. O'Brien RM. A caution regarding rules of thumb for variance inflation factors. Qual Quantity 2007; 41: 673-90.
28. Kraemer HC, Stice E, Kazdin A, et al. How do risk factors work together? Mediators, moderators, and independent, overlapping, and proxy risk factors. Am J Psychiatry 2001; 158: 848-56. (Pubitemid 32547610)
29. Baron RM, Kenny DA. The moderatoremediator variable distinction in social psychological research: conceptual, strategic, and statistical considerations. J Pers Soc Psychol 1986; 51: 1173-82.
30. Hedreen JC, Struble RG, Whitehouse PJ, et al. Topography of the magnocellular basal forebrain system in human brain. J Neuropathol Exp Neurol 1984; 43: 1-21. (Pubitemid 14187676)
31. Cobb SR, Davies CH. Cholinergic modulation of hippocampal cells and circuits. J Physiol 2005; 562: 81-8. (Pubitemid 40207787)
32. Cole AE, Nicoll RA. Acetylcholine mediates a slow synaptic potential in hippocampal pyramidal cells. Science 1983; 221: 1299-301. (Pubitemid 13001282)
33. Berger-Sweeney J. The effects of neonatal basal forebrain lesions on cognition: towards understanding the developmental role of the cholinergic basal forebrain. Int J Dev Neurosci 1998; 16: 603-12. (Pubitemid 29151751)
34. Torres EM, Perry TA, Blockland A, et al. Behavioural, histochemical and biochemical consequences of selective immunolesions in discrete regions of the basal forebrain cholinergic system. Neuroscience 1994; 63: 95-122. (Pubitemid 24333955)
35. Hashimoto M, Kazui H, Matsumoto K, et al. Does donepezil treatment slow the progression of hippocampal atrophy in patients with Alzheimer's disease? Am J Psychiatry 2005; 162: 676-82. (Pubitemid 40489128)
36. Krishnan KR, Charles HC, Doraiswamy PM, et al. Randomized, placebo-controlled trial of the effects of donepezil on neuronal markers and hippocampal volumes in Alzheimer's disease. Am J Psychiatry 2003; 160: 2003-11. (Pubitemid 39619638)
37. Bottino CM, Castro CC, Gomes RL, et al. Volumetric MRI measurements can differentiate Alzheimer's disease, mild cognitive impairment, and normal aging. Int Psychogeriatr 2002; 14: 59-72. (Pubitemid 34625564)
38. Muller MJ, Greverus D, Dellani PR, et al. Functional implications of hippocampal volume and diffusivity in mild cognitive impairment. Neuroimage 2005; 28: 1033-42. (Pubitemid 41713637)
39. Kantarci K, Petersen RC, Przybelski SA, et al. Hippocampal volumes, proton magnetic resonance spectroscopy metabolites, and cerebrovascular disease in mild cognitive impairment subtypes. Arch Neurol 2008; 65: 1621-8.
40. Hamalainen A, Grau-Olivares M, Tervo S, et al. Apolipoprotein E epsilon 4 allele is associated with increased atrophy in progressive mild cognitive impairment: a voxel-based morphometric study. Neurodegener Dis 2008; 5: 186-9. (Pubitemid 351347846)
41. Dubelaar EJ, Verwer RW, Hofman MA, et al. ApoE epsilon4 genotype is accompanied by lower metabolic activity in nucleus basalis of Meynert neurons in Alzheimer patients and controls as indicated by the size of the Golgi apparatus. J Neuropathol Exp Neurol 2004; 63: 159-69. (Pubitemid 38174781)